Interview with a ketamine chemist
An investigation into methoxetamine (3-MeO-2-Oxo-PCE), an arylcyclohexylamine ketamine derivative that has recently appeared on the research chemical market. By Hamilton Morris for Vice.
M. is one of the most respected chemists in his underground field. Singlehandedly, he has popularized and discovered numerous novel drugs for gray-market distribution. His most recent investigation of ketamine and its chemical variations produced a new dissociative anesthetic named methoxetamine, which has recently made its way into the nostrils and anuses of lay experimenters worldwide. Methoxetamine is an exemplary product of rational drug discovery; each of its atoms is the result of arduous study and consideration, all created independently on a minuscule budget. But the success of drugs like methoxetamine does not entail great profits for their inventors. Indeed, it is they who wring their hands most over the unknown fate of the chemicals they conceive. Herein we shall explore the great bioethical quandary faced by the underground medicinal chemist.
» More ways to bookmark this page
|
Recently @ DoseNation
|
|
Also I find it funny the images associated with each one.
The comments posted here do not reflect the views of the owners of this site.